Elsevier Appoints Martin O'Malley as Managing Director of New Global Sales Group in Science & Technology Division

AMSTERDAM, July 1, 2010 - Elsevier, the leading publisher of scientific, technical and medical
information, has appointed Martin O'Malley as Managing Director of the newly
formed Global Sales & Customer Marketing group in the Science & Technology
(S&T) division, which includes the sales teams for Academic & Government,
Books and Corporate Markets, effective 1 July.

O'Malley's appointment follows the announced departure of Roy Jakobs,
Managing Director for Academic & Government Sales and Customer Marketing.
Jakobs will be leaving Elsevier this summer to take a senior position in the
lighting division of Philips.

"Martin O'Malley is a leader who brings great knowledge of Elsevier's
customers to his new position," said Youngsuk Chi, Vice Chairman and CEO S&T.
"In Martin, we have a leader who has on-the-ground experience in the
Americas, Europe and the Asia Pacific region, as well as experience with a
wide range of customers and partners across academic and government research,
education, and corporate research and development," he added.

"I am very excited about this new role and our continued strong focus on
the needs of customers in the academic, government, corporate, and
professional communities," said Martin O'Malley. "At the same time, by
bringing together the wider Elsevier sales and marketing effort, we expect to
further improve our ability to address shared needs across different customer
groups," he continued.

O'Malley's position as Managing Director of Corporate Markets will be
taken over by Alexander van Boetzelaer, who will spearhead the continuing
effort to develop Elsevier's corporate business.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes
more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact: Harald Boersma, Elsevier, Tel: +31-20-485-27-36, h.boersma at elsevier.com